Christopher Seder to Neoplasm Staging
This is a "connection" page, showing publications Christopher Seder has written about Neoplasm Staging.
Connection Strength
1.786
-
Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
Score: 0.689
-
The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer. Ann Surg Oncol. 2020 Aug; 27(8):3030-3036.
Score: 0.161
-
Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma. Anticancer Res. 2018 04; 38(4):2195-2200.
Score: 0.139
-
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
Score: 0.134
-
Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1.
Score: 0.122
-
Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus. Anticancer Res. 2015 Nov; 35(11):6159-62.
Score: 0.118
-
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma. Anticancer Res. 2015 Nov; 35(11):6325-7.
Score: 0.118
-
Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16.
Score: 0.098
-
Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia. 2009 Apr; 11(4):388-96.
Score: 0.075
-
The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer. Ann Thorac Surg. 2020 03; 109(3):848-855.
Score: 0.039
-
Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
Score: 0.037
-
Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
Score: 0.028
-
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
Score: 0.027